Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Bairati

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|January 18, 2019
A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancerViannique Rolland, François Meyer, Matthieu J Guitton, et al.
Gynecologic Oncology|September 13, 2012
Human epididymis protein 4 (HE4) and ovarian cancer prognosisDominique Trudel, Bernard Têtu, Jean Grégoire, et al.
Cancer|February 27, 2010
Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancerAlice Nourissat, Isabelle Bairati, Elodie Samson, et al.
BMC Cancer|January 12, 2018
Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trialMarie-Hélène Guertin, Karine Robitaille, Jean-François Pelletier, et al.
Plos One|June 21, 2019
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancerDaniela Furrer, Jean Grégoire, Stéphane Turcotte, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2014
Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosisDominique Trudel, Patrice Desmeules, Stéphane Turcotte, et al.
International Journal of Cancer|November 22, 2012
Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patientsAbul Kalam Azad, Isabelle Bairati, Xin Qiu, et al.
Diagnostic Pathology|August 23, 2018
HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysisAndréanne Gagné, Bernard Têtu, Michèle Orain, et al.
Diagnostic Pathology|September 19, 2018
Correction to: HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysisAndréanne Gagné, Bernard Têtu, Michèle Orain, et al.
Molecular Oncology|August 23, 2011
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancerPierre-Luc Mercier, Magdalena Bachvarova, Marie Plante, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|January 18, 2019
A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancerViannique Rolland, François Meyer, Matthieu J Guitton, et al.
Gynecologic Oncology|September 13, 2012
Human epididymis protein 4 (HE4) and ovarian cancer prognosisDominique Trudel, Bernard Têtu, Jean Grégoire, et al.
Cancer|February 27, 2010
Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancerAlice Nourissat, Isabelle Bairati, Elodie Samson, et al.
BMC Cancer|January 12, 2018
Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trialMarie-Hélène Guertin, Karine Robitaille, Jean-François Pelletier, et al.
Plos One|June 21, 2019
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancerDaniela Furrer, Jean Grégoire, Stéphane Turcotte, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 8, 2014
Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosisDominique Trudel, Patrice Desmeules, Stéphane Turcotte, et al.
International Journal of Cancer|November 22, 2012
Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patientsAbul Kalam Azad, Isabelle Bairati, Xin Qiu, et al.
Diagnostic Pathology|August 23, 2018
HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysisAndréanne Gagné, Bernard Têtu, Michèle Orain, et al.
Diagnostic Pathology|September 19, 2018
Correction to: HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysisAndréanne Gagné, Bernard Têtu, Michèle Orain, et al.
Molecular Oncology|August 23, 2011
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancerPierre-Luc Mercier, Magdalena Bachvarova, Marie Plante, et al.
Pageof 6